Cross Infection: Clinical Trials

11 trials for Cross Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 unknown. 11 Phase 3, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 311Unknown 11
Phase 26Unknown 6

Follow Cross Infection: new trials by email Literature Review of Cross Infection trials Research Report on Cross Infection

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
"Baricitinib for Treating Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype.
Baricitinib 4 MG - Hospital-acquired Pneumonia
Phase 2 / Phase 3UnknownNantes University Hospital4502023-07-012023-06-22
Different Oral Colonization of Gram-negative Bacteria in ICU Patients When Using Chlorhexidine at 0.12% Versus Chlorhexidine at 2.0%
Chlorhexidine gluconate at 2%, Chlorhexidine gluconate at 0.12% - Chlorhexidine, Ventilator Associated Pneumonia
Phase 3UnknownUniversidad de Guanajuato742019-02-012019-03-11
Short Infusion Versus Prolonged Infusion of Ceftolozane-tazobactam Among Patients with Ventilator Associated-pneumonia
1 hour infusion, 4 hours infusion - Ventilator-associated Pneumonia
Phase 3UnknownUniversity Hospital, Toulouse802018-09-202024-09-25
Air-impingement Manipulation to Clear Subglottic Secretion to Prevent VAP in Prolonged Intubated Patients
Manual air-impingement operation, subglottic secretion drainage - Ventilator Associated Pneumonia
Phase 3UnknownBeijing Chao Yang Hospital2202016-01-012015-12-16
The Effect of Ulinastatin on Bronchoalveolar Lavage Fluid of Inflammatory Factors in Patients With Ventilator-associated Pneumonia
Ulinaststin for injection, placebo - Ventilator-associated Bacterial Pneumonia, Mechanical Ventilation Complication
Phase 2 / Phase 3UnknownShanghai Minhang Central Hospital602014-01-012013-05-30
Simplified Selective Digestive Tract Decontamination for the Prevention of Intensive Care Unit Acquired Infections
Neomycin Colistin Nystatin Vancomycin - Bacteremia Associated With Intravascular Line, Ventilator Associated Pneumonia
Phase 2 / Phase 3UnknownRambam Health Care Campus24002013-06-012013-02-26
Optimizing Dosing Regimen of Piperacillin/Tazobactam for Nosocomial Pneumonia
C Group, E Group - Nosocomial Pneumonia
Phase 2 / Phase 3UnknownTianjin Medical University Cancer Institute and Hospital502012-03-012016-02-17
Pharmacokinetics of Nebulized Amikacin in Patients With Pneumonia Undergoing Mechanical Ventilation
Nebulized amikacin, Intravenous amikacin, Placebo nebulization - Ventilator Associated Pneumonia
Phase 2 / Phase 3UnknownAssociation Pour La Promotion A Tours De La Reanimation Medicale242009-01-012009-03-16
Intravenous Colistin Versus Intravenous Colistin Plus Nebulized Colistin in VAP Due MDR Acinetobacter Baumannii
Colistin, Colistin and saline solution - Cross Infection, Pneumonia, Bacterial
Phase 3UnknownHospitales Universitarios Virgen del Rocío672008-04-012009-08-06
Nebulized Colistin for Hospital-Acquired Pneumonia
nebulized colistin, antibiotics - Pneumonia
Phase 3UnknownMahidol University1402006-06-012009-06-15
Effectiveness of Dental Brushing for Preventing Ventilator-Associated Pneumonia
Toothbrushing - Ventilator-Associated Pneumonia, Nosocomial Pneumonia
Phase 2 / Phase 3UnknownHospital Universitari Joan XXIII de Tarragona.4002005-05-012009-02-12

Narrower conditions

Pneumonia, Ventilator-Associated (8)  ·  Healthcare-Associated Pneumonia (4)  ·  Pneumonia (4)  ·  Bacteremia (1)  ·  Pneumonia, Bacterial (1)  ·  Pseudomonas Infections (1)

Broader conditions

Disease Attributes (11)  ·  Iatrogenic Disease (11)  ·  Infections (11)  ·  Lung Diseases (11)  ·  Pathologic Processes (11)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Respiratory Tract Diseases (11)  ·  Respiratory Tract Infections (11)  ·  Healthcare-Associated Pneumonia (7)  ·  Pneumonia (7)  ·  Bacterial Infections (3)  ·  Bacterial Infections and Mycoses (3)  ·  Gram-Negative Bacterial Infections (1)  ·  Inflammation (1)

Interventions

Colistin (2)  ·  Anti-Bacterial Agents (1)  ·  Injections (1)  ·  Neomycin (1)  ·  Powders (1)  ·  Saline Solution (1)  ·  Toothbrushing (1)  ·  Vancomycin (1)  ·  baricitinib (1)  ·  ceftolozane, tazobactam drug combination (1)

Sponsors

Association Pour La Promotion A Tours De La Reanimation Medicale (1)  ·  Beijing Chao Yang Hospital (1)  ·  Hospital Universitari Joan XXIII de Tarragona. (1)  ·  Hospitales Universitarios Virgen del Rocío (1)  ·  Mahidol University (1)  ·  Nantes University Hospital (1)  ·  Rambam Health Care Campus (1)  ·  Shanghai Minhang Central Hospital (1)  ·  Tianjin Medical University Cancer Institute and Hospital (1)  ·  Universidad de Guanajuato (1)  ·  University Hospital, Toulouse (1)

Countries

France (3)  ·  Spain (3)  ·  China (2)  ·  Belgium (1)  ·  Israel (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Thailand (1)

Top investigators

Jiwei Li (1)  ·  Jordi Rello, MD, PhD (1)  ·  Jose A Alvarez, PhD (1)  ·  Mical Paul, Prof. (1)  ·  Visanu Thamlikitkul, MD (1)  ·  Wang Donghao, Chief (1)  ·  Yaron P Bar-Lavie, M.D. (1)

Results publications

PMID 10816031, PMID 17872488, PMID 18641114, PMID 19482956, PMID 20936977, PMID 22186217, PMID 23583261, PMID 23727136, PMID 24969718, PMID 25343570

NIH funding

2018 (1)